In Hee Kim1, Tatiana Kisseleva, David A Brenner. 1. aDepartment of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea bDepartment of Internal Medicine, School of Medicine, University of California, San Diego, La Jolla, California, USA.
Abstract
PURPOSE OF REVIEW: Aging is a condition in which a person gradually loses the ability to maintain homeostasis, due to structural alteration or dysfunction. Aging is a major risk factor for most chronic diseases. As the liver has a remarkable ability to regenerate, this review assessed the effect of aging on clinical liver disease with references to preclinical models when relevant to pathogenesis. RECENT FINDINGS: Aging has been shown to not only enhance vulnerability to acute liver injury but also increase susceptibility of the fibrotic response. Aging is associated with the severity and poor prognosis of various liver diseases including nonalcoholic fatty liver disease, alcoholic liver disease, hepatitis C, and liver transplantation. SUMMARY: Treatment of older patients with liver disease may require different or longer interventions. Transplantation of an older liver will be less tolerant of subsequent injury. Future studies are needed to understand more about the molecular mechanism of aging and contribute to the development of a noble treatment strategy that can block the progression of aging-induced liver diseases.
PURPOSE OF REVIEW: Aging is a condition in which a person gradually loses the ability to maintain homeostasis, due to structural alteration or dysfunction. Aging is a major risk factor for most chronic diseases. As the liver has a remarkable ability to regenerate, this review assessed the effect of aging on clinical liver disease with references to preclinical models when relevant to pathogenesis. RECENT FINDINGS: Aging has been shown to not only enhance vulnerability to acute liver injury but also increase susceptibility of the fibrotic response. Aging is associated with the severity and poor prognosis of various liver diseases including nonalcoholic fatty liver disease, alcoholic liver disease, hepatitis C, and liver transplantation. SUMMARY: Treatment of older patients with liver disease may require different or longer interventions. Transplantation of an older liver will be less tolerant of subsequent injury. Future studies are needed to understand more about the molecular mechanism of aging and contribute to the development of a noble treatment strategy that can block the progression of aging-induced liver diseases.
Authors: Norma E López-Diazguerrero; Armando Luna-López; María C Gutiérrez-Ruiz; Alejandro Zentella; Mina Königsberg Journal: Life Sci Date: 2005-10-14 Impact factor: 5.037
Authors: Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba Journal: Hepatology Date: 2013-10-02 Impact factor: 17.425
Authors: Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane Journal: N Engl J Med Date: 2013-04-23 Impact factor: 91.245
Authors: Jasmohan S Bajaj; Andres Duarte-Rojo; Jesse J Xie; Chathur Acharya; James B Wade; Carlos Robles; Leroy R Thacker; Christopher Flud; Andrew Fagan; Mauricio Garcia-Saenz-de-Sicilia; Melanie B White; Megan Kelly; Vy Nguyen; Edith A Gavis; Hugo E Vargas Journal: Clin Gastroenterol Hepatol Date: 2020-03-20 Impact factor: 11.382
Authors: Jian Xing; Philip R Spradling; Anne C Moorman; Scott D Holmberg; Eyasu H Teshale; Loralee B Rupp; Stuart C Gordon; Mei Lu; Joseph A Boscarino; Mark A Schmidt; Connie M Trinacty; Fujie Xu Journal: Dig Dis Sci Date: 2017-09-30 Impact factor: 3.199